Page last updated: 2024-08-21

isoxazoles and Anti-MuSK Myasthenia Gravis

isoxazoles has been researched along with Anti-MuSK Myasthenia Gravis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, P; Deng, J; Feng, H; Liu, W; Luo, Y; Ou, C; Qiu, L1
Apostolski, S; Bartlett, RR; Damjanovic, M; Isakovic, K; Kosec, D; Vidic-Dankovic, B1

Other Studies

2 other study(ies) available for isoxazoles and Anti-MuSK Myasthenia Gravis

ArticleYear
Leflunomide treatment in corticosteroid-dependent myasthenia gravis: an open-label pilot study.
    Journal of neurology, 2016, Volume: 263, Issue:1

    Topics: Activities of Daily Living; Adolescent; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Myasthenia Gravis; Pilot Projects; Prednisone; Treatment Outcome; Young Adult

2016
Leflunomide prevents the development of experimentally induced myasthenia gravis.
    International journal of immunopharmacology, 1995, Volume: 17, Issue:4

    Topics: Animals; Autoantibodies; Autoimmune Diseases; Female; Flow Cytometry; Immunization; Immunosuppressive Agents; Isoxazoles; Leflunomide; Myasthenia Gravis; Rats; Rats, Inbred Strains; Receptors, Cholinergic; T-Lymphocyte Subsets; Thymus Gland; Time Factors; Torpedo

1995